After administration of GTE the increase in progesterone levels causes a reduction in LH with a feedback effect on the pituitary-ovarian axis and an increase in ovulation rates in polycystic ovaries [21, 28, 45]. The gene discussed is PLOD1; the disease is polycystic ovary syndrome.